TrialBMC cancer2015

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial).

Andrea Camerini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.